Wordt geladen...
Allogeneic GM-CSF Secreting Tumor Immunotherapy (GVAX(®)) Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility and Immune Activation
PURPOSE: The combination of chemotherapy and immunotherapy has not been examined in patients with advanced pancreatic cancer. We conducted a study of two GM-CSF secreting pancreas cancer cell lines (CG8020/CG2505) as immunotherapy administered alone or in sequence with Cy in patients with advanced p...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879140/ https://ncbi.nlm.nih.gov/pubmed/18316569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-0371 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|